Qiagen Licenses DNA Amplification Technology from Genetrix | GenomeWeb

NEW YORK (GenomeWeb News) – Spanish biotechnology holding company Genetrix today announced it has licensed its Qualiphi polymerase product to Qiagen.

The global, exclusive deal was reached through Genetrix's X-Pol subsidiary.

Qualiphi is a DNA polymerase licensed from the Spanish National Research Council and studies suggest that it may improve the amplifications of whole genomes and large stretches of DNA, Genetrix said.

Financial and other terms of the deal were not disclosed.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: experts say race is not a sufficient proxy for studying human genetic diversity and more.

Technology Review writes that CRISPR/Cas9 gene editing firm Editas' success may hinge on a patent case.

Researchers unearthed a bioinformatics error in the Science paper reporting the first ancient African genome, and the authors are seeking an erratum.

A boy's cystic fibrosis carrier status was revealed by a teacher to the parents of children with CF who then sought the boy's transfer to another school, leading to a lawsuit.